← brief for 2026-09-28 · Slowing decline

Effectiveness of Adding GLP-1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study.

Article C Peer reviewed Observational

Key takeaways

This study looked at people with chronic kidney disease. It compared taking one diabetes drug to taking two. It checked for major kidney and heart events. It shows a link between the treatments and health outcomes, but it is not proof of cause.

Who did this work

Salim H · Qureshi S · Gulsin GS · Khan HR · Waqas SA · McCann GP · Garg A · Shurrab M · Khunti K · Rashid M

Source

Article · PubMed, the drug frontier · 2026 Sep 27
https://pubmed.ncbi.nlm.nih.gov/42802242/